Enforcement Report - Week of October 5, 2022
Alembic Pharms`s Generic Clomipramine HCl Receives Approval In US
Alembic announces USFDA Final Approval for Clomipramine Hydrochloride Capsules
Enforcement Report - Week of December 2, 2020
Ajanta Pharma Ltd's Generic Clomipramine Hydrochloride Receives Approval In US
Unique Pharm`s Generic Clomipramine Hydrochloride Receives Approval in US
Tulex Pharms` Generic Clomipramine Hydrochloride Receives Approval in US
Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, announced that Jubilant Pharma Limited, a material wholly owned subsidiary of the company, through one of its wholly owned subsidiaries, has received Abbreviated New Drug Application (ANDA) final approval from US FDA for clomipramine hydrochloride capsules USP 25mg, 50mg and 75mg, the generic version of Anafranil of SpecGx LLC, which is used for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).
Jubilant Cadista Pharma`s Generics Clomipramine Hcl Receives Approval In US
Lupin' Generic Clomipramine Hydrochloride Receives Approval in US